Recent literature has increasingly reported on a clinical entity found in the fellow eyes of patients undergoing treatment for unilateral exudative neovascular age-related macular degeneration (nAMD). Multiple terms have been used to describe it, including nonexudative macular neovascularisation (neMNV), subclinical choroidal neovascularisation and quiescent choroidal neovascularisation1. Each term implies the presence of new vessels in the macula tissue without signs of exudation, such as intraretinal fluid, subretinal fluid, and subretinal pigment epithelial fluid2.
Premium subscriber content
Sign in if you have a Digital or Print + Digital subscription. Don’t have one yet? Digital subscribers get full access to this article from $40/year +GST.
- Premium exclusive content
- Full digital magazine archive
- Early access to new articles
